ECFCs (EndGenitor)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameECFCs (EndGenitor)
Drug Alias Nameadult stem cell therapy (EndGenitor)cord blood-derived endothelial colony forming cells (EndGenitor)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIschemiaDiabetes MellitusMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEndGenitor Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndGenitor Technologies Inc
Active IndicationsN/A
Inactive IndicationsIschemiaDiabetes MellitusMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A